These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Inhibitory effects of Pinus massoniana bark extract on hepatitis C virus in vitro.
    Author: Wang C, Zhang L, Cheng P, Zhang Q.
    Journal: Pharm Biol; 2015 Mar; 53(3):451-6. PubMed ID: 25471218.
    Abstract:
    CONTEXT: Given that Pinus massoniana Lamb (Pinaceae) bark extract (PMBE) is a safe and non-toxic flavonoid found abundantly in nature, it was considered a promising novel candidate agent in the treatment of virus infection. OBJECT: Experiments were conducted to assay the antiviral character of PMBE against Hepatitis C virus (HCV). MATERIALS AND METHODS: Assay of PMBE cytotoxicity, HCV replication, infectious HCV production, and its potential influence on the pathways for IFN-ISRE and NS3 protease were conducted. RESULTS: HCV replication was suppressed when the concentration of PMBE raised greater than 5 μg/mL and its EC50 was 9.58 μg/mL. In the 10 μg/mL group, HCV replication was suppressed for 48 h. When the concentration increased to 40 μg/mL, HCV replication was significantly suppressed (luciferase activity was only 10% at 96 h). PMBE could inhibit HCV virus production efficiently (PMBE group was 5 FFU). Cell viability was affected by 40 μg/mL of PMBE. The F/R ratio ranged from 98% to 101%. The rate of OD450 ranged from 96% to 102%. NS3 catalytic activity ranged from 5% (40 μg/mL PMBE) to 45% (5 μg/mL PMBE). Even when used in a low amount (5 μg/mL), NS3 catalytic activity was significantly inhibited (p < 0.01). CONCLUSIONS: The results suggest that PMBE is effective for use in the stabilization of HCV replication and active liver inflammation.
    [Abstract] [Full Text] [Related] [New Search]